Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home  /  Forum  /  Crucell  /  Maanddraad September

Ontvang nu dagelijks onze kooptips!

word abonnee

Crucell« Terug naar discussie overzicht

Maanddraad September

266 Posts
Pagina: «« 1 ... 9 10 11 12 13 14 | Laatste | Omlaag ↓
  4. [verwijderd] 28 september 2008 19:11
    Publication Date:09/18/2008

    Title:Method for simultaneous production of multiple proteins; vectors and cells for use therein

    Document Type and Number:United States Patent 20080227199

    Abstract:Described is the production of proteins in a host cell. More specifically, described are methods for improving expression of two or more proteins in a cell or host cell. The methods are suited for production of, for example, recombinant antibodies that can be used in pharmaceutical preparations or as diagnostic tools. In one embodiment, provided is a method for obtaining a cell that expresses two or more proteins comprising providing the cell with two or more protein expression units encoding two or more proteins, characterized in that at least two of the protein expression units comprise at least one STAR sequence.
    www.freepatentsonline.com/y2008/02271...
  5. [verwijderd] 29 september 2008 08:36
    INTERVIEW: ROUNDTABLE DISCUSSION ON BIOTECH/PHARMA DEALS - Martina Molsbergen, VP, Business Development, Crucell; Barbara Yanni, Chief Licensing Officer, Merck & Co.; David Colpman, Senior VP, Business Development, Shire Pharmaceuticals; and Joern-Peter Halle, Head, Early-Stage Licensing, Merck Serono, a division of Merck KGaA

    In the Wall Street Biobeat column of the September 1st issue of GEN, Robert Dellenbach wrote that significant changes in the global economy and in the venture capital community have dramatically impacted the life sciences industry. What's more, his article appeared even before last month's near Wall Street meltdown. What's a biotech company to do for money?

    GEN held a roundtable discussion with several industry professionals to find out. We discovered that dealmaking with pharma firms was on a dramatic upswing, and not just due to a lack of VC funding. The panel answered questions such as: What's driving the recent spate of deals, especially all the M&A and partnering activities between pharmaceutical companies and biotech firms? What does a pharma firm look for in a biotech company before entering such deals? What does a biotech company need to do to get the attention of a large pharmaceutical company? Does it seem like deals, and not drug products themselves or specific technologies, are now the main driving force behind the bio industry's growth?

    Anyone involved in the biotechnology industry will find this podcast extremely compelling and timely as the biopharmaceutical industry continues to search for new and creative avenues of financing!

    www.genengnews.com/genCasts.aspx
266 Posts
Pagina: «« 1 ... 9 10 11 12 13 14 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 887,44 +0,99%
EUR/USD 1,0762 0,00%
FTSE 100 8.213,49 +0,51%
Germany40^ 18.017,10 +0,67%
Gold spot 2.301,75 0,00%
NY-Nasdaq Composite 16.156,33 +1,99%

Stijgers

VIVORY...
+7,18%
Flow T...
+4,87%
BESI
+4,11%
Brunel
+3,91%
UMG
+3,62%

Dalers

HEIJMA...
-5,17%
Aperam
-4,56%
AMG Cr...
-3,16%
Kendrion
-2,75%
CM.COM
-2,24%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!